Clinical pearls for frontline PCPsA 40-year-old man on today’s schedule has a chief complaint of “excruciating headaches.” ...
The decision by the EC was supported by data from the Myasthenia Gravis Inebilizumab Trial.
Amgen's Uplizna receives European approval to treat generalized myasthenia gravis: Thousand Oaks, California Saturday, February 14, 2026, 11:00 Hrs [IST] Amgen announced the Europ ...
Amgen (NASDAQ:AMGN) today announced the European Commission (EC) has approved UPLIZNA® (inebilizumab) as an add-on treatment to ...
Late-breaking KEYNOTE-B15 data show KEYTRUDA ® (pembrolizumab) plus Padcev ® (enfortumab vedotin-ejfv) significantly improved event-free survival, overall survival and pathologic complete response ...
A new guideline provided recommendations on benzodiazepine tapering when risks outweigh benefits. Tapering strategy should be adjusted to each patient based on their response, guideline authors said.
Everyday Health on MSN
How to manage steroid side effects during AAV treatment
Corticosteroids can be an effective way to treat ANCA-associated vasculitis. Get to know steroids’ risks, from gaining weight ...
BESTOW Phase II: The study did not meet its primary kidney-function endpoint but met the non-inferiority margin for the widely accepted composite endpoint (biopsy-proven rejection plus patient/graft ...
Belimumab combined with standard induction therapy is effective and safe in patients with proliferative lupus nephritis, according to a real-world study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results